同花順(300033.SZ)一季度淨利潤預增0%-30%
格隆匯2月24日丨同花順(300033.SZ)公佈,預計2020年第一季度歸屬於上市公司股東的淨利潤1億元-1.31億元,同比增長0%-30%。
2020年一季度因新型冠狀病毒疫情的衝擊,企業復工生產受到了影響,國內A股市場也出現較大波動。為儘可能降低疫情對行業及公司業務發展,公司積極應對,研發了高效的遠程協同雲辦公系統,滿足公司業務及行業創新發展的需要;同時,公司強化管理,提質增效,確保安全有序復工。另外,2019年末預收款項有所上升,導致2020年一季度滿足條件後確認的營業收入同比有所增長。因此,2020年第一季度歸屬於上市公司股東的淨利潤呈現一定程度的增長。
預計非經常性損益為200萬元-500萬元,主要為公司收到的投資收益、政府補助資金等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.